Amino acid restriction modulates tumor growth, although effects on metastasis are poorly documented. We demonstrate that low levels of tyrosine (Tyr) and phenylalanine (Phe) suppress metastasis of B16-BL6 melanoma and that these effects are specific to these two amino acids. Weight loss and sustained low body weight in mice fed low Tyr and Phe diet do not contribute to the antimetastatic effects. Furthermore, methionine (Met) restriction, which decreased survival of mice inoculated i.p. with B16 melanoma, only slightly inhibited spontaneous metastasis compared to the dramatic inhibition during Tyr and Phe restriction. Tyr and Phe restriction inhibited spontaneous metastasis by impairing the ability of tumor cells to establish metastatic foci and not via differential tumor cell removal from the blood. Spontaneous metastasis is blocked by Tyr and Phe intervention even in mice with established lymph node tumors. Tumors isolated from mice fed low Tyr and Phe diet reinoculated into mice fed normal diet exhibited lower experimental metastatic potential, reflected by decreased formation of lung tumor colonies and increased survival of inoculated mice. This decrease in metastatic potential is not associated with tumor chemosensitivity. These findings indicate that Tyr and Phe restriction could become an important adjuvant to effective melanoma treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abell, C. W., Hodgins, D. S., and Stith, W. J., 1973, An in vivo evaluation of the chemotherapeutic potency of phenylalanine ammonia-lyase. Cancer Research, 33, 2529–2532.
[2]Abdallah, R. M., Starkey, J. R., and Meadows, G. G., 1987, Dietary restriction of tyrosine and phenylalanine: Inhibition of metastasis of three rodent tumors. Journal of the National Cancer Institute, 78, 759–769.
Abdallah, R. M., Starkey, J. R., and Meadows, G. G., 1983, Alcohol and related dietary effects on mouse natural killer-cell activity. Immunology, 50, 131–137.
Abou-El-Ela, S. H., Prasse, K. W., Farrell, R. L., Carroll, R. W. Wade, A. E., and Bunce, O. R., 1989, Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Research, 49, 1434–1440.
Allison, D. C., Bose, K. K., Anderson, S., Curley, S., and Robertson, J., 1989, Slowing of cell cycle traverse for cells in exponential monolayer cultures placed into plateau-fed and starved medium. Cancer Research, 49, 1456–1464.
Asselin, B. L., Ryan, D., Frantz, C. N., Bernal, S. D., Leavitt, P., Sallan, S. E., and Cohen, H. J., 1989, In vitro and in vivo killing of acute lymphoblastic leukemia cells by l-asparaginase. Cancer Research, 49, 4363–4368.
Girt, D. F., White, L. T., Choi, B., and Pelling, J. C., 1989, Dietary fat effects on the initiation and promotion of two-stage skin tumorigenesis in the SENCAR mouse. Cancer Research, 49, 4170–4174.
Bounous, G., and Kongshavn, P. A. L., 1978, The effect of dietary amino acids on immune reactivity. Immunology, 35, 257–266.
Bounous, G., Sadarangani, C., Pang, K. C., and Kongshavn, P. A. L., 1981, Effect of dietary amino acids on tumor growth and cell mediated immune responses. Clinical Investigations in Medicine, 4, 109–115.
Boylan, E. S., and Cohen, L. A., 1986, The influence of dietary fat on mammary tumor metastasis in the rat. Nutrition and Cancer, 8, 193–200.
Branda, R. F., McCormack, J. J., Perlmutter, C. A., Mathews, L. A., and Robison, S. H., 1988, Effects of folate deficiency on the metastatic potential of murine melanoma cells. Cancer Research, 48, 4529–4534.
Breillout, F., Poupon, M. F., Blanchard, P., Lascaux, V., Echinard-Garin, P., and Robert-Gero, M., 1988, Association of SIBA treatment and a Met-depleted diet inhibits in vitro growth and in vivo metastatic spread of experimental tumor cell lines. Clinical and Experimental Metastasis, 6, 3–16.
Brown, J. M., and Parker, E. T., 1979, Host treatments affecting artificial pulmonary metastases: interpretation of loss of radioactivity labelled cells from lungs. British Journal of Cancer, 40, 677–688.
Cillo, C., Dick, J. E., Ling, V., and Hill, R. P., 1987, Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines. Cancer Research, 47, 2604–2608.
Conley, F. K., 1982, Effect of immunomodulation of the fate of tumor cells in the central nervous system and systemic organs of mice. Distribution of [125I]5-iodo-2′-deoxyuridine-labeled KHT tumor cells after left intracardial injection. Journal of the National Cancer Institute, 69, 465–473.
Demetrakopoulos, G. Ev., and Brennan, M. F., 1982, Tumoricidal potential of nutritional manipulations. Cancer Research, 42, 756s–765s.
Demopoulos, H. B., 1966, Effects of low phenylalanine-tyrosine diets on S91 mouse melanomas. Journal of the National Cancer Institute, 37, 185–190.
Elmer, G. W., Linden, C., and Meadows, G. G., 1979, Influence of l-tyrosine phenollyase on the growth and metabolism of B16 melanoma. Cancer Treatment Reports, 63, 1055–1062.
Elmer, G. W., Meadows, G. G., Linden, C., Digiovanni, J., and Holcenberg, J., 1976, Influence of tyrosine phenol-lyase and phenylalanine ammonia-lyase on growth of B-16 melanoma. Pigment Cell, Vol. 2, edited by V. Riley (Basel: S. Karger AG), pp. 339–346.
Ershler, W. B., Berman, E., and Moore, A. L., 1986, Slower B16 melanoma growth but greater pulmonary colonization in calorie-restricted mice. Journal of the National Cancer Institute, 76, 81–85.
Fidler, I. J., 1970, Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2′-deoxyuridine. Journal of the National Cancer Institute, 45, 773–782.
Gardiner, N. S., and Duncan, J. R., 1989, Inhibition of murine melanoma growth by sodium ascorbate. Journal of Nutrition, 119, 586–590.
Goldie, J. H., and Coldman, A. J., 1979, A mathematical model for relating the drug sensitivity of tumors to the spontaneous mutation rate. Cancer Treatment Reports, 63, 1727–1733.
Hart, I. R., 1979, The selection and characterization of an invasive variant of the B16 melanoma. American Journal of Pathology, 97, 587–600.
Hart, I. R., and Fidler, I. J., 1981, The implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis. Biochimica et Biophysica Acta, 651, 37–50.
Heppner, G. H., and Miller, B. E., 1983, Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Review, 2, 5–23.
Hoffman, R. M., 1982, Methionine dependence in cancer cells—A review. In vitro, 18, 421–428.
Hoffman, R. M., 1985, Altered methionine metabolism and transmethylation in cancer. Anticancer Research, 5, 1–30.
Jones, R. C., Sugie, S., Braley, J., and Weisburger, J. H., 1989, Dietary β-carotene in rat models of gastrointestinal cancer. Journal of Nutrition, 119, 508–514.
Jose, D. G., and Good, R. A., 1973, Quantitative effects of nutritional essential amino acid deficiency upon immune responses to tumors in mice. Journal of Experimental Medicine, 137, 1–9.
Juacaba, S. F., Horak, E., Price, J. E., and Tarin, D., 1989, Tumor cell dissemination patterns and metastasis of murine mammary carcinoma. Cancer Research, 49, 570–575.
Judde, J. G., Ellis, M., and Frost, P., 1989, Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Research, 49, 4859–4865.
Katz, E. B., and Boylan, E. S., 1989, Effects of reciprocal changes of diets differing in fat content on pulmonary metastasis from the 13762 rat mammary tumor. Cancer Research, 49, 2477–2484.
Legha, S. S., 1989, Current therapy for malignant melanoma. Seminars in Oncology, 16, 33–44.
Liteplo, R. G., 1989, Altered methionine metabolism in metastatic variants of a human melanoma cell line. Cancer Letters, 44, 23–31.
Lorincz, A. B., Kuttner, R. B., and Brandt, M. B., 1969, Tumor response to phenylalanine-tyrosine limited diets. Journal of the American Dietetic Association, 54, 198–205.
Meadows, G. G., Abdallah, R. M., and Starkey, J. R., 1986, Interaction between specific dietary factors and experimental chemotherapy of metastatic melanoma. Cancer Chemotherapy and Pharmacology, 16, 229–236.
Meadows, G. G., Abdallah, R. M., Starkey, J. R., and Aslakson, C. J., 1988, Response of natural killer cells from dietary tyrosine and phenylalanine restricted mice to biological response modifiers. Cancer Immunology and Immunotherapy, 26, 67–73.
Meadows, G. G., Digiovanni, J., Minor, L., and Elmer, G. W., 1976, Some biological properties and an in vivo evaluation of tyrosine phenol-lyase on the growth of B16 melanoma. Cancer Research, 36, 167–171.
Meadows, G. G., and Oeser, D. E., 1983, Response of B16 melanoma-bearing mice to varying levels of phenylalanine and tyrosine. Nutrition Reports International, 28, 1073–1082.
Meadows, G. G., Pierson, H. F., Abdallah, R. M., and Desai, P. R., 1982, Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopalevodopa methyl ester chemotherapy. Cancer Research, 42, 3056–3063.
Medina, D., and Oborn, C. J., 1981, Differential effects of selenium on the growth of mouse mammary cells in vitro. Cancer Letters, 13, 333–344.
Miller, T. J., Franco, R. S., Chance, W. T., Martelo, J., and Popp, M. B., 1987, Amino acid requirements of a rat sarcoma as determined by a stem cell assay. Journal of Parenteral and Enteral Nutrition, 11, 223–228.
Noto, V., Taper, H. S., Yi-hua, J., Janssens, J., Bonte, J., and Deloecker, W., 1989, Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. Cancer, 63, 901–906.
Nowell, P. C., 1976, The clonal evolution of tumor cell populations. Science, 194, 23–28.
Patterson, M. K., 1972, Uptake and utilization of amino acids by cell cultures. Growth, Nutrition, and Metabolism of Cells in Culture, edited by G. H. Rothblast and V. J. Cristofalo (New York: Academic Press), pp. 171–209.
Pezzuto, J. M., Shieh, H.-L., Shaughnessy, E., and Beattie, C. W., 1988, Approaches for drug development in treatment of advanced melanoma. Seminars in Oncology, 15, 578–588.
Pierson, H. F., and Meadows, G. G., 1983, Sodium ascorbate enhancement of carbidopa-methyl ester antitumor activity against pigmented B16 melanoma. Cancer Research, 43, 2047–2051.
Pierson, H. F., and Meadows, G. G., 1985, Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation. Journal of the National Cancer Institute, 75, 507–516.
Pine, M. J., 1978, Effect of low phenylalanine diet on murine leukemia Ll210. Journal of the National Cancer Institute, 60, 633–641.
Pine, M. J., 1981, Improved host defense against L1210 leukemia by deprivation of dietary phenylalanine. Nutrition and Cancer, 3, 94–102.
Price, J. E., and Tarin, D., 1982, Retention of ‘metastatic’ colonisation potential by cells of spontaneous primary tumors after cryopreservation. British Journal of Cancer, 45, 790–793.
Reinhold, U., Biltz, H., Bayer, W., and Schmidt, K. H., 1989, Serum selenium levels in patients with malignant melanoma. Acta Dermatovenereologica (Stockholm), 69, 132–136.
Rogers, A. E., Nields, H. M., and Newberne, P. M., 1987, Nutritional and dietary influences on liver tumorigenesis in mice and rats. Archives of Toxicology (Suppl. 10), 231–243.
Ross, D. W., and Capizzi, R. L., 1984, Differentiation versus cytoreduction during remission induction in acute nonlymphoblastic leukemia treated with sequential highdose ara-C and asparaginase. Cancer, 53, 1651–1654.
Ruggeri, B. A., Klurfeld, D. M., Kritchevsky, D., and Furlanetto, R. W., 1989, Growth factor binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors from rat subject to chronic caloric restriction. Cancer Research, 49, 4135–4141.
Ruggeri, B. A., Klurfeld, D. M., Kritchevsky, D., and Furlanetto, R. W., 1989, Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: Alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Research, 49, 4130–4134.
Sallan, S. E., Hitchcock-bryan, S., Gelber, R., Cassady, J. R., Frei, 111, E., and Nathan, D. G., 1983, Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Research, 43, 5601–5607.
Silverman, J., Powers, J., Stromberg, P., Pultz, J. A., and Kent, S., 1989, Effects on C3H mouse mammary cancer of changing from a high fat to a low fat diet before, at, or after puberty. Cancer Research, 49, 3857–3860.
Stackpole, C. W., Cremona, P., and Kassel, R. L., 1979, Metrizamide gradient purification of mouse tumor cells. Journal of Immunological Methods, 30, 231–243.
Stern, P. H., and Hoffman, R. M., 1986, Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. Journal of the National Cancer Institute, 76, 629–639.
Sundram, K., Khor, H. T., Ong, A. S. H., and Pathmanathan, R., 1989, Effect of dietary palm oils on mammary carcinogenesis in female rats induced by 7,12-dimethylbenz(a)anthracene. Cancer Research, 49, 1447–1451.
Talmadge, J. E., Benedict, K., Madsen, J., and Fidler, I. J., 1984, Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases. Cancer Research, 44, 3801–3805.
Theuer, R. C., 1971, Effect of essential amino acid restriction on the growth of female C57BL mice and their implanted BW 10232 adenocarcinomas. Journal of Nutrition, 101, 223–232.
van Eys, J., 1985, Nutrition and cancer: physiological interrelationships. Annual Review of Nutrition, 5, 435–461.
Vanhamme, L., and Szpirer, C., 1989, Spontaneous and 5-azacytidine-induced revertants of methionine-dependent tumor-derived and H-ras-l-transformed cells. Experimental Cell Research, 181, 159–168.
Xiang, J., and Kimura, A. K., 1986, In vitro modulation of the metastatic phenotype. I. Analysis of differentiation forms of the B16 melanoma expressing Met-72 determinants and metastatic activity. Clinical and Experimental Metastasis, 4, 293–309.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elstad, C.A., Meadows, G.G. & Abdallah, R.M. Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction. Clin Exp Metast 8, 393–416 (1990). https://doi.org/10.1007/BF00058152
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00058152